Chris MacDonald

Chris MacDonald

Chris MacDonald is an MBA (finance) graduate with extensive experience covering small-, mid- and large-cap companies in the U.S. and Canadian markets. Chris is interesting in uncovering long-term and deep-value opportunities for investors based on principles from the Graham-Buffett school of thought, and looks forward to bringing investors a unique fundamental-based perspective on opportunities available in today’s challenging investing environment.

His experience as a financial analyst in the past, coupled with his fervor for finding undervalued growth opportunities, contribute to his conservative, long-term investing perspective.

Recent Articles

Mortgage Rates 2024: This Is the Magic Number That Will Unstick the Housing Market

Here's where some experts, analysts and homebuyers think mortgage rates in 2024 need to be to free up supply.

Beware This Battery Stock: Why QuantumScape’s Latest Moves Demand Investor Caution

Read this QS stock analysis to discover where the company is headed in the future, including for this year and beyond.

Surprise! Why Warren Buffet’s Apple Stock Trim Is Actually a Buy Opportunity for Investors.

Here's why long-term growth investors simply can't go wrong buying this company according to the AAPL stock analysis.

Is NIO Stock a Buy or Sell in This Uncertain EV Market?

Read this NIO stock analysis to discover whether investors should dump their shares or add more to their holdings.

The 2 Best and 1 Worst Cryptos to Buy and Sell in 2024

Here are two cryptos to buy, and one to sell, for investors looking for ways to play this rather uncertain crypto market in 2024.

Piper Sandler Just Slashed Its Price Target on Teladoc (TDOC) Stock

Investors in Teladoc may be looking to move on from this telemedicine company, with shares of TDOC stock plunging 25% today.

Worried About Layoffs? 3 Passive Income Opportunities to Consider Now

For investors looking to create passive income opportunities, the good news is there are some great options out there. Here are three.

Why Is Emergent BioSolutions (EBS) Stock Up 70% Today?

Investors in Emergent Biosolutions and EBS stock certainly have a big catalyst to cheer today, as the company announced a new CEO.

The Return of Meme Cryptos? 3 Altcoins Ready to Ride the Crypto Revivial Higher

If meme cryptos do see a resurgence in investor interest, these three digital assets could be poised to have a nice boom in short order.

Good News for Bitcoin Holders! 3 Reasons Why We’ll See $100,000 By 2025

Here are three reasons why crypto bulls may want to give Bitcoin a hard look heading into what could be a massive bull run.